Levi Stone
Family · Willis, TXNPI 1700565785
Payments from drug & device makers
Across 133 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$334
- Dexcom, Inc.$272
- Lilly USA, LLC$241
- Amgen$224
- AbbVie$185
- Astellas Pharma US Inc$182
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,44296%
- Education$1004%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $334 |
| Dexcom, Inc. | 12 | $272 |
| Lilly USA, LLC | 16 | $241 |
| Amgen | 15 | $224 |
| AbbVie | 10 | $185 |
| Astellas Pharma US Inc | 4 | $182 |
| Exact Sciences | 9 | $145 |
| Novo Nordisk | 7 | $121 |
| Axsome Therapeutics, Inc. | 5 | $118 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $112 |
| Otsuka America Pharmaceutical, Inc. | 6 | $103 |
| Pfizer | 4 | $97 |
| Tolmar, Inc. | 5 | $82 |
| Antares Pharma, Inc. | 4 | $61 |
| Inspire Medical Systems, Inc. | 2 | $50 |
| GSK | 2 | $30 |
| Viatris Specialty LLC | 1 | $27 |
| Johnson & Johnson | 1 | $24 |
| Halozyme Inc | 1 | $23 |
| Corcept Therapeutics | 1 | $21 |
| Ironwood Pharmaceuticals, Inc | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Sumitomo Pharma America, Inc. | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
How this compares
$2,542 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 101 | $111,315 |
| MounjaroTirzepatide | 47 | $51,237 |
| JardianceEmpagliflozin | 34 | $46,897 |
| EliquisApixaban | 33 | $45,568 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 44 | $29,934 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $24,465 |
| RexultiBrexpiprazole | 11 | $21,472 |
| FarxigaDapagliflozin Propanediol | 13 | $20,481 |
| Tresiba Flextouch U-100Insulin Degludec | 17 | $13,950 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 41 | $5,915 |
| Testosterone Cypionate | 49 | $3,621 |
| Levothyroxine Sodium | 244 | $3,401 |
| Gabapentin | 166 | $2,983 |
| PaxlovidNirmatrelvir/Ritonavir | 13 | $2,797 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $2,384 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $121 | $111,315101 claims |
| Lilly USA, LLCMounjaro | $241 | $51,23747 claims |
| AstraZenecaBreztri Aerosphere, Farxiga | $334 | $50,41557 claims |
| PfizerEliquis, Paxlovid | $97 | $48,36546 claims |
| GSKTrelegy Ellipta | $30 | $24,46530 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $103 | $21,47211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 15,456 family providers in Texas.
Other family in Willis
- Tara DraehnWillis$35K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.